Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder

Pathology and Oncology Research

Volumn 16, Issue 1, 2010, Pages 101-109

  Hazzaa, Sahar M ^a   Elashry, Osama M ^a   Afifi, Ibtesam K ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

Bladder cancer; Clusterin; Over expression; Prognosis; Tumor marker

Indexed keywords

CLUSTERIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINALYSIS;

ADULT; CARCINOMA, TRANSITIONAL CELL; CLUSTERIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 77949639799     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9196-3     Document Type: Article

References (35)

1. J Irani A Heidenreich N Mottet, et al. 2008 What is new in bladder cancer diagnosis and management? Eur Urol supplements 7 484 493 10.1016/j.eursup.2008. 01.003
2. A Haitel B Posch M El-Baz, et al. 2001 Bilharzial related organ confined muscle-invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, e-cadherin, epidermal growth factor receptor and c-erbB-2 J Urol 165 1481 1487 10.1016/S0022-5347(05)66332-X 1:CAS:528: DC%2BD3MXjvVaitb0%3D 11342901
3. F Millan-Rodriguez G Chechile-Toniolo J Salvador-Bayarri, et al. 2000 Primary superficial bladder cancer risk groups according to progression, mortality and recurrence J Urol. 164 680 684 10.1016/S0022-5347(05)67280-1 1:STN:280:DC%2BD3cvjtVSmsA%3D%3D 10954628
4. RS Cajulis GK Haines 3rd D Frias-Hidvegi, et al. 1995 Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study Diagn. Cytopathol. 13 3 214 224 10.1002/dc.2840130307 1:STN:280:DyaK287islCqtA%3D%3D 8575280
5. BJ Schmitz-Dräger Y Fradet HB Grossman 2008 Bladder cancer markers in patient management: the current perspective World J Urol 26 1 3 10.1007/s00345-007-0225-0 18060549
6. O Blaschuk K Burdzy IB Fritz 1983 Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid J Biol Chem. 258 7714 7720 1:CAS:528:DyaL3sXktlCktbY%3D 6863260
7. DE Jenne J Tschopp 1992 Clusterin: the intriguing guises of a widely expressed glycoprotein Trends Biochem Sci. 17 154 159 10.1016/0968-0004(92) 90325-4 1:CAS:528:DyaK38XitlShur0%3D 1585460
8. SE Jones C Jomary 2002 Clusterin Int J Biochem Cell Biol. 34 427 431 10.1016/S1357-2725(01)00155-8 1:CAS:528:DC%2BD38XitFWit7o%3D 11906815 (Pubitemid 34242756)
9. B Shannan M Seifert K Leskov, et al. 2006 Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer Cell Death and Differentiation J. 13 12 19 10.1038/sj.cdd.4401779 1:CAS:528:DC%2BD2MXht1yktbjM
10. K Parczyk C Pilarsky U Rachel, et al. 1994 Gp80 (Clusterin: TRPM-2) mRNA levels is enhanced in human renal clear cell carcinomas J Cancer Res Clin Oncol 120 186 188 10.1007/BF01202200 1:STN:280:DyaK2c%2Fos1Gqug%3D%3D 8263017
11. J Steinberg R Oyasu S Lang, et al. 1997 Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer Clin Cancer Res 3 1707 1711 1:CAS:528:DyaK2sXmvFGqtrs%3D 9815554
12. M Redondo E Villar J Torres-Muñoz, et al. 2000 Overexpression of Clusterin in human breast carcinoma Am J Pathol 157 393 399 1:CAS:528: DC%2BD3cXlvFyru7s%3D 10934144
13. H Miyake M Gleave S Kamidono, et al. 2002 Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence Urology 50 150 154 10.1016/S0090-4295(01)01484-4 (Pubitemid 34059338)
14. S Krüger A Mahnken I Kausch, et al. 2006 Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma Urology 67 1 105 109 10.1016/j.urology.2005.04.043 16413343 (Pubitemid 43069266)
15. JI Epstein MB Amin VR Reuter, et al. 1998 The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder Am J Surg Pathol 22 1435 1448 10.1097/00000478-199812000-00001 1:STN:280:DyaK1M%2FmsFChsA%3D%3D 9850170 (Pubitemid 28550639)
16. J Park J Park S Ju, et al. 2003 Clusterin mRNA expression in apoptotic and activated rat thymocytes Cell Research 13 1 49 58 10.1038/sj.cr.7290150 1:CAS:528:DC%2BD2cXivVSit7Y%3D 12643349 (Pubitemid 43231861)
17. Petrie A, Sabin C (2005) Medical Statistics at a Glance. 2nd ed.,Blackwell Publishing
18. IP Trougakso A So B Jansen, et al. 2004 Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress Cancer Res. 64 1834 1842 10.1158/0008-5472.CAN-03-2664 (Pubitemid 38428709)
19. M Gleave H Miyake 2005 Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer World J. Urol. 23 38 46 10.1007/s00345-004-0474-0 1:CAS:528:DC%2BD2MXit1OlsLs%3D 15770517 (Pubitemid 40430679)
20. P Wong T Ulyanova DT Organisciak, et al. 2001 Expression of multiple forms of clusterin during light-induced retinal degeneration Curr Eye Res 23 157 165 10.1076/ceyr.23.3.157.5463 1:STN:280:DC%2BD38%2FnsFCjsQ%3D%3D 11803476 (Pubitemid 34497354)
21. KS Leskov DY Klokov J Li, et al. 2003 Synthesis and functional analyses of nuclear clusterin, a cell death protein J. Biol. Chem. 278 11590 11600 10.1074/jbc.M209233200 1:CAS:528:DC%2BD3sXit1Kgtb0%3D 12551933 (Pubitemid 36792721)
22. S Pucci E Bonanno F Pichiorri, et al. 2004 Modulation of different clusterin isoforms in human colon tumorigenesis Oncogene 23 2298 2304 10.1038/sj.onc.1207404 1:CAS:528:DC%2BD2cXisVGksLc%3D 14755245 (Pubitemid 38496784)
23. X Chen RB Halberg WM Ehrhardt, et al. 2003 Clusterin as a biomarker in murine and human intestinal neoplasia Proc. Natl. Acad. Sci. USA 100 9530 9535 10.1073/pnas.1233633100 1:CAS:528:DC%2BD3sXmtlyku70%3D 12886021 (Pubitemid 37033962)
24. H Saffer A Wahed GZ Rassidakis, et al. 2002 Clusterin expression in malignant lymphomas Mod. Pathol. 15 1221 1223 10.1097/01.MP.0000036386.87517.AA 12429802 (Pubitemid 35435141)
25. D Stejskal RR Fiala 2006 Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer Neoplasma. 53 4 343 346 1:CAS:528:DC%2BD28XosValsrs%3D 16830064
26. H Miyake I Hara ME Gleave, et al. 2004 Protection of androgen dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen Prostate 61 318 323 10.1002/pros.20087 1:CAS:528:DC%2BD2cXhtFWqtr%2FO 15389725 (Pubitemid 39564276)
27. T Zellweger S Kiyama K Chi, et al. 2003 Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model BJU Int. 92 463 469 10.1046/j.1464-410X.2003.04349.x 1:CAS:528:DC%2BD3sXotVeksLc%3D 12930442 (Pubitemid 37100531)
28. M Scaltriti M Brausi A Amorosi 2004 Clusterin (SGP-2, APOJ) expression is downregulated in low- and high-grade human prostate cancer Int. J. Cancer 108 23 30 10.1002/ijc.11496 1:CAS:528:DC%2BD3sXps1entL4%3D 14618611 (Pubitemid 37444439)
29. LV July E Beraldi A So, et al. 2004 Nucleotide-based therapies targeting clusterin chemosensitized human lung adenocarcinoma cells both in vitro and in vivo Mol. Cancer Ther. 3 223 232 1:CAS:528:DC%2BD2cXitFCnsrg%3D 15026542
30. LY Zhang WT Ying YS Mao 2003 Loss of clusterin both in serum and tissue correlates with the tumorigenesis of oesophageal squamous cell carcinoma via proteomic approaches World J Gastroenterol 9 650 654 1:CAS:528: DC%2BD3sXjs1agsL0%3D 12679903
31. MJ Xie Y Motoo SB Su, et al. 2002 Expression of clusterin in human pancreatic cancer Pancreas 25 234 238 10.1097/00006676-200210000-00004 12370533
32. H Miyake I Hara S Kamidono, et al. 2001 Synergistic chemosensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model Clin Cancer Res 7 4245 4252 1:CAS:528:DC%2BD38XltFSgtQ%3D%3D 11751526
33. H Miyake C Nelson PS Rennie, et al. 2000 Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene, testosterone-repressed prostate message-2, in prostate cancer xenograft models Cancer Res 60 2547 2554 1:CAS:528:DC%2BD3cXjtV2qtb8%3D 10811138
34. H Miyake KN Chi ME Gleave 2000 Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgenindependent PC-3 prostate cancer cells both in vitro and in vivo Clin Cancer Res 6 1655 1663 1:CAS:528:DC%2BD3cXktVWisrw%3D 10815883
35. H Miyake I Hara S Kamidono, et al. 2001 Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting antiapoptotic genes up-regulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity Int J Urol 8 337 349 10.1046/j.1442-2042.2001.00311.x 1:CAS:528:DC%2BD3MXmtVGnurs%3D 11442654 (Pubitemid 34225114)